HMAO-B/MB-COMT-IN-1

HMAO-B/MB-COMT-IN-1 is a dual MAO-B/MB-COMT inhibitor (IC50s: 2.5 μΜ for hMAO-B, 3.84 μΜ for MB-COMT) . hMAO-B/MB-COMT-IN-1 protects cells against oxidative damage. hMAO-B/MB-COMT-IN-1 can be used in the research of neurodegeneration disease, such as Parkinson’s Disease (PD) [1].

Product Specifications

CAS Number

[254974-70-4]

UNSPSC

12352005

Target

COMT; Monoamine Oxidase

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease; Neuronal Signaling

Applications

Neuroscience-Neurodegeneration

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/hmao-b-mb-comt-in-1.html

Purity

98.04

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

OC1=C(C=CC(/C=C/C=C/C(N2CCCCC2)=O)=C1)O

Molecular Formula

C16H19NO3

Molecular Weight

273.33

References & Citations

[1]Daniel Chavarria, et al. Boosting caffeic acid performance as antioxidant and monoamine oxidase B/catechol-O-methyltransferase inhibitor. Eur J Med Chem. 2022 Sep 8;243:114740.